Abstract:Cancer represents the leading public health problem throughout the world. Globally, about one out of six deaths is related to cancer, which is largely due to the metastatic lesions. However, there are no effective strategies for targeting cancer metastasis. Identification of the key druggable targets maintaining metastasis is crucial for cancer treatment. In our recent study (Cai et al. (2020), Mol Cell, doi: 10.1016/j.molcel.2020.09.018), we found that activity of AMPK was enriched in metastatic tumors compared to primary tumors. Depletion of AMPK rendered cancer cells more sensitive to metabolic and oxidative stress, leading to the impairment of breast cancer lung metastasis. Activation of AMPK rewired cancer metabolism towards TCA cycle, which protects disseminated cancer cells from both metabolic and oxidative stress-induced cell death, and facilitates cancer metastasis. Further, AMPK critically maintained the activity of pyruvate dehydrogenase complex (PDH), the rate limiting enzyme involved in TCA cycle, thus favoring the pyruvate metabolism towards TCA cycle rather than converting it to lactate. Mechanistically, AMPK was shown to co-localize with PDHA, the catalytic subunit of PDH, in the mitochondrial matrix and directly triggered the phosphorylation of PDHA on Ser295 and Ser314. Hyper-phosphorylation of Ser295 and Ser314 of PDHA promotes lung metastasis through elevating activity of PDH. Of note, PDHA Ser314 phosphorylation abrogated the interaction between PDHA and PDHKs leading to the dephosphorylation on previously reported S293 site, whose phosphorylation serves as a negative signal for PDH activation, while S295 phosphorylation serves as an intrinsic catalytic site required for pyruvate metabolism. Our study presented the first evidence for the pro-metastatic property of the AMPK-PDH axis and advance our current understanding of how PDH is activated under physiological and pathological conditions.

Targeting AMPK for cancer prevention and treatment.

AMPK as a metabolic tumor suppressor: control of metabolism and cell growth

Role of AMP-activated protein kinase in cancer therapy

AMPK: The energy sensor at the crossroads of aging and cancer

AMP-activated Protein Kinase and Energy Balance in Breast Cancer.

The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment

AMPK signalling in health and disease

AMP‐activated Protein Kinase Regulates Cancer Cell Growth and Metabolism Via Nuclear and Mitochondria Events

AMPK as a Therapeutic Target for Treating Metabolic Diseases

AMPK and Cancer.

Functional Characterization of AMP-activated Protein Kinase Signaling in Tumorigenesis

Research progress of AMPK participation in tumor cell energy metabolism

AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules

Therapeutic strategies targeting AMPK-dependent autophagy in cancer cells

AMPK activation reduces cancer cell aggressiveness via inhibition of monoamine oxidase A (MAO-A) expression/activity

Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer

AMPK maintains TCA cycle through sequential phosphorylation of PDHA to promote tumor metastasis

AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome

AMPK as a New Attractive Therapeutic Target for Disease Prevention: The Role of Dietary Compounds AMPK and Disease Prevention